Hearn Jay Cho, MD, PhD, of the Multiple Myeloma Research Foundation, looks back on 15 years of the groundbreaking CoMMpass genomic study.
Hearn Jay Cho, MD, PhD
Advertisement
Hearn Jay Cho, MD, PhD, is an associate professor of medicine (hematology and medical oncology) at the Icahn School of Medicine at Mount Sinai.
Articles by Hearn Jay Cho, MD, PhD
Hearn Jay Cho, MD, PhD, discusses the goals of the CureCloud study, an historic initiative of the Multiple Myeloma Research Foundation (MMRF), a leader in the acceleration of efforts to provide precisely the right treatment for each and every patient.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Does Not Approve 177Lu-Edotreotide for GEP-NETs
2
Cost-Effectiveness of Perioperative Pembro in Head and Neck Cancer Hinges on PD-L1 Expression
3
Talquetamab Shows Durable Responses in R/R MM at 3-Year Follow-Up
4
Dr Lonial on Using MRD Negativity to Guide Maintenance Discontinuation in Myeloma
5